期刊文献+

慢性HBV感染者外周血单个核细胞CTLA-4基因多态性与病情转归的关联研究

Study on association between the single nucleotide polymorphism of cytotoxic T lymphocyte associated agent 4 gene exon 1 region and outcome of patients with hepatitis virus B infection
下载PDF
导出
摘要 目的初步探讨慢性HBV感染者外周血细胞毒性T淋巴细胞相关抗原-4(CTLA-4)基因第1外显子区49位基因单核苷酸多态性(singlenucleotide polymorphism,SNP)与乙型肝炎病毒感染转归的关系。方法采用聚合酶链式反应-限制性片段长度多态性法检测190例慢性HBV感染者和93例既往HBV感染者外周血CTLA-4基因49位点的多态性。结果慢性HBV感染者CTLA-4基因49位点A/G基因型分布与对照组比较差异有显著性(P=0.034),慢性感染者G等位基因频率明显低于对照组(0.561对0.677,P=0.008,OR=0.607)。结论CTLA-4第1外显子49位基因多态性可能与乙型肝炎病毒感染慢性化相关。 Objective To investigate the association between the single nucleotide polymorphism of cytotoxic T lymphocyte associated agent 4(CTLA-4)gene exon 1 region(+49)and the outcome of patients with hepatitis virus B infection. Method The restriction fragment length polymorphism-polymerase ehain reaction was used to analyze the CTLA-4 exon 1+49 polymorphism in 190 patients with chronic hepatitis B and 93 controls with past HBV infection. Results The frequency of MG genotype at the +49 site was statistically different in controls and in chronic hepatitis B patients (P〈 0.05). The frequency of G allele at the +49 site was statistically lower in chronie hepatitis B patients than in controls (0.561 vs 0.677,P〈0.01 ). Conclusion The G allele of CTLA-4 exon 1+49 polymorphism is highly related to the clinical outcomes of hepatitis B viral infection.
出处 《实用肝脏病杂志》 CAS 2008年第5期297-299,共3页 Journal of Practical Hepatology
基金 国家自然科学基金资助项目(30771907)
关键词 乙型肝炎 细胞毒性T淋巴细胞相关抗原-4 单核苷酸多态性 Hepatitis B Cytotoxic T-lymphocyte associated agent 4 Single nucleotide polymorphism
  • 相关文献

参考文献11

  • 1HOHLER T,GERKEN G,NOTGHI A,et al. HLA-DRBI*1301 and*1302 protect against chronic hepatitis B [J]. J Hepatol, 1997,26 : 503-507.
  • 2LEE WM. Hepatitis B virus infection [J]. N Engl J Med, 1997,337 : 1733-1745.
  • 3THURSZ MR. Genetic susceptibility in chronic viral hepatitis[J]. Antiviral Res, 2001,52 : 113-116.
  • 4WEATHERALL D,CLEGG J,KWIATKOWSKI D. The role of genomics in studying genetic susceptibility to infectious disease[J]. Genome Res, 1997,7:967-973.
  • 5CHAMBERS CA,KUHNS MS,EGEN JG,et al. CTLA-4-mediated inhibition in regulation of T cell responses :mechanisms and manipulation in tumor immunotherapy [J]. Annu Rev Immunol, 2001,19 : 565-594.
  • 6AGARWAL K,CZAJA AJ,JONE DE,et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis [J]. Hepatology, 2000,31:49-53.
  • 7AHMED S,IHARA K,KANEMITSU SH,et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population [J]. Rheumatology, 2001,40 : 662-667.
  • 8IHARA K,AHMED S,NAKAO F,et al. Association studies of CTLA-4,CD28,and ICOS gene polymorphisms with type 1 diabetes in the Japanese population [J]. Immunogenetics, 2001,53 : 447-454.
  • 9KOUKI T,SAWAI Y,GARDINE CA,et al. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves'disease [J]. J Immunol,2000,165: 6606-6611.
  • 10YEE LJ,PEREZ KA,TANG J,et al. Association of CT- LA-4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection[J]. J Infect Dis, 2003 ,187 :1264-1271.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部